Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purposes of this prospective study were to evaluate the successful rate of primary culture of hepatocellular carcinoma cells and cancer-associated fibroblasts from the residual specimens in routine fine-needle aspiration of hepatic tumor and the potential application of this method as an additional tool for personalized treatment of hepatocellular carcinoma patients.
| Condition |
|---|
|
Hepatocellular Carcinoma |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Kaohsiung Medical University Hospital |
- growth speed of cultured cells [ Time Frame: 28 days after plating of cells ] [ Designated as safety issue: No ]correlation the growth speed of cells (reach equal or more than 70% growth area of 25 cm2 culture flask) and TNM tumor staging
- TNM tumor staging [ Time Frame: 6 months after plating of cells ] [ Designated as safety issue: No ]change in tumor staging
- survival of patient [ Time Frame: 6 months after plating of cells ] [ Designated as safety issue: No ]correlation the growth speed of cultured cells measured at 28 days after plating (reach equal or more than 70% growth area of 25 cm2 culture flask)and cancer-related death of patient within 6 months after plating of cells
Biospecimen Retention: Samples With DNA
cancer cells and cancer-associated fibroblasts
| Estimated Enrollment: | 100 |
| Study Start Date: | April 2010 |
Fine-needle aspiration (FNA) cytology or biopsy of hepatic tumor is frequently applied in the collection of specimens because it is considered safe, efficacious, accurate and cost effective. Our previous study from small number of patients showed that specimens obtained from FNA had potential to be applied for primary culture of cancer cells. This study was to modified our method for primary culture of both hepatocellular carcinoma cells and cancer-associated fibroblasts in patients with tumor measuring larger than or equal to 3cm. All patients received one session of aspiration for the diagnosis of hepatic tumor. The aspirated specimens were applied for both cytologic and pathologic examinations at first. After then, 10 mL 0.9% NaCl was aspirated by the same needle connected with the same syringe and injected into 15 mL sterilized centrifugation tube. If the tube contained visible specimens, these specimens were sent for primary culture.
Eligibility| Ages Eligible for Study: | 20 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
patients with hepatic tumor measuring larger than or equal to 3 cm underwent fine-needle aspiration of tumor for diagnosis.
Inclusion Criteria:
- patients had residual aspirated specimens for primary culture.
Exclusion Criteria:
- patients did not have residual aspirated specimens for primary culture.
Contacts and Locations| Contact: Zu Y Lin, MD | 886-7-323-4553 | linzuyau@yahoo.com.tw |
| Taiwan | |
| Kaohsiung Medical University Hospital | Recruiting |
| Kaohsiung, Taiwan, 807 | |
| Contact: Zu Y Lin, MD 886-7-323-4553 linzuyau@yahoo.com.tw | |
| Principal Investigator: Zu Y Lin, MD | |
| Principal Investigator: | Zu Y Lin, MD | Kaohsiung Medical University |
More Information
Publications:
| Responsible Party: | Kaohsiung Medical University Chung-Ho Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT01549275 History of Changes |
| Other Study ID Numbers: | 990043 |
| Study First Received: | February 7, 2012 |
| Last Updated: | March 6, 2012 |
| Health Authority: | Taiwan: Department of Health Taiwan: Institutional Review Board |
Additional relevant MeSH terms:
|
Carcinoma Carcinoma, Hepatocellular Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Adenocarcinoma |
Liver Neoplasms Digestive System Neoplasms Neoplasms by Site Digestive System Diseases Liver Diseases |
ClinicalTrials.gov processed this record on May 19, 2013